Barclays
SSAAW

Barclays’s Science Strategic Acquisition Corp. Alpha Warrant SSAAW Stock Holding History

Barclays’s Portfolio SSAAW Stock Details SSAAW Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2022
Q4 		– Sell
-333
Closed – – 5537
2022
Q3 		$0 Hold
333
– – ﹤0.01% 5298
2022
Q2 		$0 Hold
333
– – ﹤0.01% 5440
2022
Q1 		$0 Buy
+333
New +$138 ﹤0.01% 5796

Barclays's SSAAW Position: Q4 2022 in Review

Barclays sold out of Science Strategic Acquisition Corp. Alpha Warrant (SSAAW) in Q4 2022, closing a stake of 333 shares.

Barclays first reported a position in SSAAW in Q1 2022 and held it in 3 quarters. The position peaked at $0 in Q3 2022. 0 funds tracked by Wall St. Rank hold SSAAW as of Q4 2022.

  • Barclays reported no remaining Science Strategic Acquisition Corp. Alpha Warrant position as of Q4 2022 after selling out during the quarter.
  • Barclays sold 333 Science Strategic Acquisition Corp. Alpha Warrant shares in Q4 2022.
  • Barclays first reported a position in Science Strategic Acquisition Corp. Alpha Warrant in Q1 2022 and held it in 3 quarters.
  • Barclays's Science Strategic Acquisition Corp. Alpha Warrant position peaked at $0 in Q3 2022.
  • 0 funds tracked by Wall St. Rank held Science Strategic Acquisition Corp. Alpha Warrant as of Q4 2022.

Based on Barclays's 13F filing for Q4 2022, filed 13 Feb 2023.